Ardent Health
ARDT
10.88
+0.20
+1.87%
Ardent Health
US · ARDT
#2983 by market cap
Listed 2024
10.88
+0.20
+1.87%
Live - 5344 symbols - heartbeat 53s ago
· 2026-10-08 07:59
Pre-market
11.00
+1.10%
After-hours
10.88
0.00%
Overnight
10.75
-1.19%
- Market cap
- 1.53B
- P/E (TTM)i
- 19.78
- P/Bi
- 1.14
- EPSi
- 0.96
- Div yieldi
- 0.00%
- 52W posi
- 41%
Reader sentiment
Are you bullish or bearish on ARDT?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
12.29 +13.0%
Price target rangecurrent 10.88
Low10.00
Avg12.29
High14.00
Buy 56%
Hold 33%
Sell 11%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-30 | Truist Financial | -- | BUY | -- |
| 2026-09-23 | BMO Capital | -- | HOLD | 11.00 |
| 2026-09-22 | BMO Capital | -- | HOLD | 11.00 |
| 2026-09-17 | Leerink Partners | -- | BUY | -- |
| 2026-08-10 | BofA Securities | -- | SELL | 10.00 |
| 2026-08-10 | Goldman Sachs | -- | HOLD | 13.00 |
| 2026-08-07 | RBC Capital | -- | BUY | 13.00 |
| 2026-08-06 | Mizuho Securities | -- | BUY | 13.00 |
| 2026-08-06 | Truist Financial | -- | BUY | 13.00 |
| 2026-08-06 | Morgan Stanley | -- | HOLD | 12.00 |
| 2026-08-06 | Goldman Sachs | -- | HOLD | 13.00 |
| 2026-08-05 | BofA Securities | -- | SELL | 9.00 |
| 2026-08-05 | Truist Financial | -- | BUY | -- |
| 2026-08-05 | Guggenheim | -- | BUY | 14.00 |
| 2026-08-04 | Goldman Sachs | -- | HOLD | 11.00 |
| 2026-07-15 | BofA Securities | -- | SELL | 9.00 |
| 2026-07-14 | Truist Financial | -- | BUY | 12.00 |
| 2026-07-09 | RBC Capital | -- | BUY | 12.00 |
| 2026-07-08 | BofA Securities | -- | SELL | -- |
| 2026-06-10 | Goldman Sachs | -- | HOLD | 12.00 |
| 2026-06-08 | Morgan Stanley | -- | HOLD | 12.00 |
| 2026-06-03 | UBS | -- | BUY | 13.50 |
| 2026-06-03 | KeyBanc | -- | HOLD | -- |
| 2026-06-03 | Goldman Sachs | -- | HOLD | 12.00 |
| 2026-06-03 | Guggenheim | -- | BUY | 13.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-04 | After close | ±14.43% | +3.81% (in line) |
| 2026/Q1 | 2026-05-05 | After close | ±12.59% | -7.50% (in line) |
| 2025/Q4 | 2026-03-04 | After close | ±13.74% | -2.07% (in line) |
| 2025/Q3 | 2025-11-12 | After close | ±19.57% | -33.81% (beat) |
| 2025/Q2 | 2025-08-05 | After close | ±10.70% | +6.10% (in line) |
| 2025/Q1 | 2025-05-06 | After close | ±11.61% | +9.22% (in line) |
| 2024/Q4 | 2025-02-26 | After close | ±12.11% | +8.21% (in line) |
| 2024/Q3 | 2024-11-06 | After close | ±21.52% | +7.81% (in line) |
| 2024/Q2 | 2024-08-14 | After close | -- | +6.06% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:59:55 · For reference only, not investment advice and not tailored to your situation.